JANE STREET GROUP, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,174,285
+55.6%
24,272
+47.9%
0.00%
Q2 2023$1,397,488
+69.3%
16,414
+64.6%
0.00%
Q1 2023$825,265
-40.6%
9,973
-43.5%
0.00%
-100.0%
Q4 2022$1,389,352
-36.3%
17,665
-40.0%
0.00%0.0%
Q3 2022$2,181,000
+173.3%
29,458
+140.6%
0.00%
Q2 2022$798,000
-29.3%
12,242
-31.4%
0.00%
Q1 2022$1,128,000
-69.2%
17,848
-74.2%
0.00%
-100.0%
Q4 2021$3,668,000
+21.1%
69,161
+61.2%
0.00%0.0%
Q3 2021$3,028,000
-10.9%
42,900
-15.8%
0.00%0.0%
Q2 2021$3,398,000
-64.7%
50,977
-41.3%
0.00%
-75.0%
Q1 2021$9,639,000
+3933.1%
86,825
+4219.7%
0.00%
Q4 2020$239,000
-96.0%
2,010
-97.1%
0.00%
-100.0%
Q3 2020$5,961,000
-80.4%
68,316
-79.9%
0.00%
-87.0%
Q2 2020$30,383,000
+5869.2%
339,239
+6538.7%
0.02%
Q1 2020$509,000
+46.3%
5,110
+68.7%
0.00%
Q4 2019$348,000
-50.6%
3,029
-45.8%
0.00%
-100.0%
Q3 2019$705,000
-29.2%
5,591
-50.9%
0.00%
-50.0%
Q1 2019$996,000
-87.9%
11,383
-87.6%
0.00%
-89.5%
Q2 2018$8,257,000
+1806.9%
92,075
+738.8%
0.02%
+850.0%
Q2 2017$433,00010,9770.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders